Trial Profile
Clinical Trials Insight: 700028166
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Nov 2007
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Sponsors Supratek Pharma
- 28 Nov 2007 Special Protocol Assessment agreement reached with the US FDA.
- 06 Nov 2007 New trial record.